
Aradhana Sasan
Examiner (ID: 9005, Phone: (571)272-9022 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1310 |
| Issued Applications | 752 |
| Pending Applications | 117 |
| Abandoned Applications | 467 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11282571
[patent_doc_number] => 09498409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Cosmetic skin covering sheets and their method of preparation'
[patent_app_type] => utility
[patent_app_number] => 14/572118
[patent_app_country] => US
[patent_app_date] => 2014-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16524
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 293
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14572118
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/572118 | Cosmetic skin covering sheets and their method of preparation | Dec 15, 2014 | Issued |
Array
(
[id] => 11113568
[patent_doc_number] => 20160310541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'A CHAMBER FOR ENCAPSULATING SECRETING CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/103108
[patent_app_country] => US
[patent_app_date] => 2014-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9529
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15103108
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/103108 | Chamber for encapsulating secreting cells | Dec 8, 2014 | Issued |
Array
(
[id] => 10265994
[patent_doc_number] => 20150150991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'NOVEL SUSTAINED RELEASE DOSAGE FORM'
[patent_app_type] => utility
[patent_app_number] => 14/562091
[patent_app_country] => US
[patent_app_date] => 2014-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5584
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562091
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/562091 | Sustained release dosage form | Dec 4, 2014 | Issued |
Array
(
[id] => 11066256
[patent_doc_number] => 20160263221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'MULTI-RESPONSIVE TARGETING DRUG DELIVERY SYSTEMS FOR CONTROLLED-RELEASE PHARMACEUTICAL FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 15/035855
[patent_app_country] => US
[patent_app_date] => 2014-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4981
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035855
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/035855 | MULTI-RESPONSIVE TARGETING DRUG DELIVERY SYSTEMS FOR CONTROLLED-RELEASE PHARMACEUTICAL FORMULATION | Nov 20, 2014 | Abandoned |
Array
(
[id] => 9901087
[patent_doc_number] => 20150056287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-26
[patent_title] => 'NANOPARTICULATE MEGESTROL FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/536539
[patent_app_country] => US
[patent_app_date] => 2014-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21525
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14536539
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/536539 | Nanoparticulate megestrol formulations | Nov 6, 2014 | Issued |
Array
(
[id] => 10201648
[patent_doc_number] => 20150086635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'NANOPARTICULATE MEGESTROL FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/536530
[patent_app_country] => US
[patent_app_date] => 2014-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21501
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14536530
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/536530 | Nanoparticulate megestrol formulations | Nov 6, 2014 | Issued |
Array
(
[id] => 13247939
[patent_doc_number] => 10136639
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Polycationic amphiphiles as antimicrobial agents
[patent_app_type] => utility
[patent_app_number] => 15/034375
[patent_app_country] => US
[patent_app_date] => 2014-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7789
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15034375
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/034375 | Polycationic amphiphiles as antimicrobial agents | Nov 4, 2014 | Issued |
Array
(
[id] => 11427939
[patent_doc_number] => 09566242
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-14
[patent_title] => 'Sustained delivery of therapeutic agents to an eye compartment'
[patent_app_type] => utility
[patent_app_number] => 14/521904
[patent_app_country] => US
[patent_app_date] => 2014-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16604
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14521904
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/521904 | Sustained delivery of therapeutic agents to an eye compartment | Oct 22, 2014 | Issued |
Array
(
[id] => 9849829
[patent_doc_number] => 08951555
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-02-10
[patent_title] => 'Controlled release hydrocodone formulations'
[patent_app_type] => utility
[patent_app_number] => 14/520032
[patent_app_country] => US
[patent_app_date] => 2014-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12901
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14520032
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/520032 | Controlled release hydrocodone formulations | Oct 20, 2014 | Issued |
Array
(
[id] => 10213986
[patent_doc_number] => 20150098978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-09
[patent_title] => 'DISSOLVABLE-CHEWABLE TABLET'
[patent_app_type] => utility
[patent_app_number] => 14/505965
[patent_app_country] => US
[patent_app_date] => 2014-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8694
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14505965
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/505965 | Dissolvable-chewable tablet | Oct 2, 2014 | Issued |
Array
(
[id] => 11766913
[patent_doc_number] => 09375428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-28
[patent_title] => 'Morphine controlled release system'
[patent_app_type] => utility
[patent_app_number] => 14/496561
[patent_app_country] => US
[patent_app_date] => 2014-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 25
[patent_no_of_words] => 21356
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 381
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14496561
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/496561 | Morphine controlled release system | Sep 24, 2014 | Issued |
Array
(
[id] => 14818543
[patent_doc_number] => 10406257
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Oily compositions
[patent_app_type] => utility
[patent_app_number] => 15/022075
[patent_app_country] => US
[patent_app_date] => 2014-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7868
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15022075
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/022075 | Oily compositions | Sep 15, 2014 | Issued |
Array
(
[id] => 11793125
[patent_doc_number] => 09402815
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-02
[patent_title] => 'High drug load mesalazine sachet'
[patent_app_type] => utility
[patent_app_number] => 14/483695
[patent_app_country] => US
[patent_app_date] => 2014-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4193
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14483695
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/483695 | High drug load mesalazine sachet | Sep 10, 2014 | Issued |
Array
(
[id] => 9916777
[patent_doc_number] => 20150071982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-12
[patent_title] => 'ANTIMICROBIAL POLYMER LAYERS'
[patent_app_type] => utility
[patent_app_number] => 14/479536
[patent_app_country] => US
[patent_app_date] => 2014-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16355
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14479536
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/479536 | Antimicrobial polymer layers | Sep 7, 2014 | Issued |
Array
(
[id] => 10996300
[patent_doc_number] => 20160193246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'POLYMERIC SYNTHETIC ANTIDOTE'
[patent_app_type] => utility
[patent_app_number] => 14/911435
[patent_app_country] => US
[patent_app_date] => 2014-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12963
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14911435
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/911435 | Polymeric synthetic antidote | Aug 7, 2014 | Issued |
Array
(
[id] => 10620543
[patent_doc_number] => 09339467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus'
[patent_app_type] => utility
[patent_app_number] => 14/451879
[patent_app_country] => US
[patent_app_date] => 2014-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18221
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14451879
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/451879 | Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus | Aug 4, 2014 | Issued |
Array
(
[id] => 10932156
[patent_doc_number] => 20140335177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/444637
[patent_app_country] => US
[patent_app_date] => 2014-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14300
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14444637
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/444637 | PHARMACEUTICAL COMPOSITION | Jul 27, 2014 | Abandoned |
Array
(
[id] => 10933257
[patent_doc_number] => 20140336278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'In Situ Gelling Drug Delivery System'
[patent_app_type] => utility
[patent_app_number] => 14/444338
[patent_app_country] => US
[patent_app_date] => 2014-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6739
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14444338
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/444338 | In situ gelling drug delivery system | Jul 27, 2014 | Issued |
Array
(
[id] => 10676262
[patent_doc_number] => 20160022407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'Prosthetic Vascular Conduits for Cardiovascular Structures'
[patent_app_type] => utility
[patent_app_number] => 14/337863
[patent_app_country] => US
[patent_app_date] => 2014-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5902
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14337863
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/337863 | Prosthetic Vascular Conduits for Cardiovascular Structures | Jul 21, 2014 | Abandoned |
Array
(
[id] => 10926826
[patent_doc_number] => 20140329847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'METHOD OF TREATING PAIN UTILIZING CONTROLLED RELEASE OXYMORPHONE PHARMACEUTICAL COMPOSITIONS AND INSTRUCTION ON DOSING FOR RENAL IMPAIRMENT'
[patent_app_type] => utility
[patent_app_number] => 14/336753
[patent_app_country] => US
[patent_app_date] => 2014-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 23043
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14336753
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/336753 | Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment | Jul 20, 2014 | Issued |